A LITERATURE REVIEW ON PATHOPHYSIOLOGY AND MODERN APPROACHES TO THE TREATMENT OF NEOVASCULAR EYE DISEASES
Keywords:
Neovascular diseases, growth factor, intravitreal injectionsAbstract
Neovascular pathology (NVD) in posterior segment the eye leads to visual deterioration or even loss in several ocular diseases. Proliferative diabetic retinopathy, neovascular age-related macular degeneration, and retinopathy of prematurity are predominant in the list of NVD. Together, these three diseases afflict persons in all stages of life from birth through late adulthood and account for most instances of legal blindness. Thus being aware of the origin, etiology and pathophysiology, clinical manifest and the modern approaches to the management and treatment of these diseases is substantial.
References
American Journal of Pathology, Vol. 153, No. 3, September 1998 Copyright © American Society for Investigative Pathology, Ocular Neovascularization Clarifying Complex Interactions, Kimberly A. Neely* and Thomas W. Gardner.
Risau W, Lemmon V: Vasculogenesis. Annu Rev Cell Dev Biol 1995, 11:73–91
Risau W: Mechanisms of angiogenesis. Nature 1997, 386:671–674
Bussolino F, Albini A, Camussi G, Presta M, Viglietto G, Ziche M, Persico G: Role of soluble mediators in angiogenesis. Eur J Cancer 1996, 32:2401–2412
Miyazono K, Usuke K, Heldin C-H: Structural and functional properties of platelet-derived endothelial cell growth factor. In Growth Factors in Health and Disease, Proceedings of the 4th Nordisk Insulin Symposium, B Westermark, C Betsholtz, B Hokfelt, editors. Elsevier Science Publishers B.V., Amsterdam, 1990, pp 281–288
Punglia RS, Lu M, Hsu J, Kuroki M, Tolentino MJ, Keough K, Levy AP, Levy NS, Goldberg MA, D’Amato RJ, Adamis AP: Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes 1997, 46:1619–1626
Ozaki H, Okamoto N, Ortega S, Chang M, Ozaki K, Sadda S, Vinores MA, Derevjanik N, Zack DJ, Basilico C, Campochiaro PA: Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. Am J Pathol 1998, 153: 757–765
Hoffman RS: The growth-activating effect of extracts of adult and embryonic tisses of rat on fibroblast colonies in vitro. Growth 1940, 4:361–376
Baird A: Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. Recent Prog Horm Res 1986, 42:143–205
Hanneken A, Wenbin Y, Ling N, Baird A: Identification of soluble forms of the fibroblast growth factor receptor in blood. Proc Natl Acad Sci USA 1994, 91:9170–9174
Hanneken A, Baird A: Soluble forms of the high-affinity fibroblast growth factor receptor in human vitreous fluid. Invest Ophthalmol Vis Sci 1995, 36:1192–1196
Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M: Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 1987, 84:2292–2296
Hanneken A, Maher PA, Baird A: High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells: implications for the modulation of FGF-2. J Cell Biol 1995, 128:1221– 1228
Broaley KN, Aquino AM, Woodward SC, Buckley-Sturrock, Sato Y, Rifkin DB, Davidson JM: Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair. Lab Invest 1989, 61:571–575
Ribatti D, Urbinati C, Nico B, Rusnati M, Roncali L, Presta M: Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev Biol 1995, 170:39–49
Gospodarowicz D, Neufeld G, Schweigerer L: Fibroblast growth factor: structural and biological properties. J Cell Physiol (suppl) 1987, 5:15–26
Montesano R, Vassalli J-D, Baird A, Guilemin R, Orci L: Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 1986, 83:7297–7301
Mignatti P, Morimoto T, Rifkin DB: Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 1992, 151:81–93
Sato K, Rifkin DB: Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 1988, 107:1199–1205
Mignatti P, Moriomoto T, Rifkin DB: Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc Natl Acad Sci USA 1991, 88:11007–11011
Mignatti P, Tsuboi R, Robbins E, Rifkin DB: In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol 1989, 108:671–682
Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27–31
O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277–285
Reed MJ, Iruela-Arispe L, O’Brien ER, Truong T, LaBell T, Bornstein P, Sage EH: Expression of thrombospondins by endothelial cells. Am J Pathol 1995, 147:1068–1080
Hiscott P, Sorokin L, Schlotzer-Schrehardt U, Bluthner K, Endress K, Mayer U: Expression of thrombospondin 1 by adult lens epithelium. Exp Eye Res 1996, 62:709–712
Hiscott P: Berthold s, Schlotzer-Schrehardt U, Naumann GOH: Immunolocalisation of thrombospondin 1 in human, bovine and rabbit cornea. Cell Tissue Res 1997, 289:307–310
Esser P, Weller M, Heimann, Wiedemann P: Thrombospondin und seine bedeutung bei proliferativen nethauterkrankungen. Fortschr Ophthalmol 1991, 88:337–340
Vogel T, Guo N, Krutzsch HC, Blake DA, Hartman J, Mendelovitz S, Panet A, Roberts DD: Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin. J Cell Biochem 1993, 53:74–84
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
